| scholarly article | Q13442814 |
| review article | Q7318358 |
| P819 | ADS bibcode | 2000PNAS...97.8829M |
| P356 | DOI | 10.1073/PNAS.97.16.8829 |
| P932 | PMC publication ID | 34019 |
| P698 | PubMed publication ID | 10922042 |
| P5875 | ResearchGate publication ID | 12398011 |
| P2093 | author name string | J J Martinez | |
| S J Hultgren | |||
| J D Schilling | |||
| M A Mulvey | |||
| P2860 | cites work | Neutrophil recruitment and resistance to urinary tract infection. | Q43553817 |
| E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells | Q45345430 | ||
| Bacteriology and ultrastructure of the bladder in patients with urinary tract infections. | Q52495940 | ||
| Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic | Q57962356 | ||
| BACTERIAL VIRULENCE IN URINARY TRACT INFECTION | Q62061199 | ||
| Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract | Q63363459 | ||
| Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli | Q64449884 | ||
| Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from the periplasm of Escherichia coli | Q64450454 | ||
| A comparative study of the desquamation of urothelial cells during gestation and in adults mice following moderate stress or endotoxin treatment | Q70932021 | ||
| Clinical implications of mast cell-bacteria interaction | Q77189215 | ||
| Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili | Q77472923 | ||
| Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection | Q77643471 | ||
| Caspases: the executioners of apoptosis | Q24530218 | ||
| Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract | Q24631903 | ||
| X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli | Q27619358 | ||
| Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination | Q28235474 | ||
| Virulence factors in Escherichia coli urinary tract infection | Q28468751 | ||
| Elevated interleukin-8 levels in the urine of patients with urinary tract infections. | Q33619559 | ||
| Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains. | Q33754925 | ||
| Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies | Q33978522 | ||
| The mammalian urinary bladder: an accommodating organ | Q34042600 | ||
| Interleukin-8 and the neutrophil response to mucosal gram-negative infection | Q34170880 | ||
| Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells | Q34173409 | ||
| Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. | Q34419957 | ||
| FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae | Q34566388 | ||
| Escherichia coli induces transuroepithelial neutrophil migration by an intercellular adhesion molecule-1-dependent mechanism | Q35444967 | ||
| Lesions in two Escherichia coli type 1 pilus genes alter pilus number and length without affecting receptor binding | Q36127265 | ||
| An electron microscopic study of the interaction between vesical epitherlium and E. Coli | Q36479701 | ||
| Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. | Q36960257 | ||
| Endotoxin-induced shedding of viable uroepithelial cells is an antimicrobial defense mechanism | Q36996985 | ||
| Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice | Q37043190 | ||
| In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections | Q37358183 | ||
| Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection | Q37371765 | ||
| Uroepithelial cells are part of a mucosal cytokine network | Q39860504 | ||
| Type 1 pilus-mediated bacterial invasion of bladder epithelial cells | Q39922793 | ||
| Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro | Q40146112 | ||
| Pleiotropic defects of IL-6-deficient mice including early hematopoiesis, T and B cell function, and acute phase responses. | Q40403937 | ||
| P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses | Q40935399 | ||
| Nonfimbrial adhesins of Escherichia coli. | Q41191653 | ||
| Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli | Q41223294 | ||
| Formation of asymmetric unit membrane during urothelial differentiation | Q41292198 | ||
| Neutrophil receptors for interleukin-8 and related CXC chemokines | Q41623891 | ||
| Pathogenesis of urinary tract infection. Role of host defenses | Q41649426 | ||
| Diagnosis and treatment of uncomplicated urinary tract infection | Q41649429 | ||
| The pathogenesis of urinary tract infections associated with Escherichia coli, Staphylococcus saprophyticus and S. epidermidis | Q42115905 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 8829-8835 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses | |
| P478 | volume | 97 |
| Q37709067 | A new paradigm of bacteria-gut interplay brought through the study of Shigella |
| Q92518050 | A shear stress micromodel of urinary tract infection by the Escherichia coli producing Dr adhesin |
| Q54514177 | Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. |
| Q40302030 | Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. |
| Q52431620 | Activation of the NLRP3 Inflammasome Pathway by Uropathogenic Escherichia coli Is Virulence Factor-Dependent and Influences Colonization of Bladder Epithelial Cells. |
| Q35949376 | Adaptor function of PapF depends on donor strand exchange in P-pilus biogenesis of Escherichia coli |
| Q39847537 | Adenosine receptor expression in Escherichia coli-infected and cytokine-stimulated human urinary tract epithelial cells |
| Q34655354 | Adhesion and entry of uropathogenic Escherichia coli. |
| Q26752944 | Adhesive Pili in UTI Pathogenesis and Drug Development |
| Q38543398 | Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis |
| Q33650044 | An Overview of Two-Component Signal Transduction Systems Implicated in Extra-Intestinal Pathogenic E. coli Infections |
| Q37695132 | An endogenous ribonuclease inhibitor regulates the antimicrobial activity of ribonuclease 7 in the human urinary tract |
| Q33982279 | Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection |
| Q35195313 | Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection |
| Q34498339 | Asymptomatic Bacteriuria in Noncatheterized Adults |
| Q34535160 | Asymptomatic bacteriuria Escherichia coli are live biotherapeutics for UTI. |
| Q45986472 | Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment. |
| Q33438417 | Bacteria-induced uroplakin signaling mediates bladder response to infection |
| Q92354803 | Bacterial Microcompartment-Mediated Ethanolamine Metabolism in Escherichia coli Urinary Tract Infection |
| Q54506870 | Bacteriuria in spinal cord injured patients with neurogenic bladder dysfunction. |
| Q54355358 | Biofilm formation and virulence of uropathogenic Escherichia coli in urine after consumption of cranberry-lingonberry juice. |
| Q35685710 | Biological costs and mechanisms of fosfomycin resistance in Escherichia coli |
| Q37227229 | Bone morphogenetic protein 4 signaling regulates epithelial renewal in the urinary tract in response to uropathogenic infection |
| Q36320615 | CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells |
| Q44220432 | CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion |
| Q34090954 | Can bacterial interference prevent infection? |
| Q37829077 | Canine bacterial urinary tract infections: new developments in old pathogens |
| Q33850497 | Cellular immunity survey against urinary tract infection using pVAX/fimH cassette with mammalian and wild type codon usage as a DNA vaccine |
| Q54537736 | Chaperone-independent folding of type 1 pilus domains. |
| Q57364626 | Chapter 4 Lipid Raft-Mediated Entry of Bacteria into Host Cells |
| Q37702318 | Characterization of hemolytic Escherichia coli strains in ferrets: recognition of candidate virulence factor CNF1. |
| Q34635273 | Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis |
| Q42441116 | Colonization of frog Rana temporaria L. urinary bladder by Gram-negative bacteria leads to decreased effect of arginine-vasotocin on water reabsorption from the urinary bladder |
| Q36757913 | Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species |
| Q30491878 | Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis |
| Q37355901 | Complicated urinary tract infection is associated with uroepithelial expression of proinflammatory protein S100A8. |
| Q47309457 | Conformational Switch of the Bacterial Adhesin FimH in the Absence of the Regulatory Domain - Engineering a Minimalistic Allosteric System |
| Q34997459 | Control, exploitation and tolerance of intracellular noise |
| Q35966152 | Covert operations of uropathogenic Escherichia coli within the urinary tract |
| Q64109069 | Covert pathogenesis: Transient exposures to microbes as triggers of disease |
| Q28361850 | Cpx signaling pathway monitors biogenesis and affects assembly and expression of P pili |
| Q33552079 | Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis |
| Q40750047 | Curli fimbria: an Escherichia coli adhesin associated with human cystitis |
| Q34975753 | Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis |
| Q51526891 | Density Shock Waves in Confined Microswimmers. |
| Q48580504 | Diagnosis and management of bladder bowel dysfunction in children with urinary tract infections: a position statement from the International Children's Continence Society |
| Q39565259 | Dietary flavonoid luteolin attenuates uropathogenic Escherichia. Coli invasion of the urinary bladder |
| Q33403069 | Different inflammatory responses are associated with Ureaplasma parvum-induced UTI and urolith formation |
| Q37379982 | Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic Escherichia coli |
| Q58730120 | Discovery of New Genes Involved in Curli Production by a Uropathogenic Escherichia coli Strain from the Highly Virulent O45:K1:H7 Lineage |
| Q37358713 | Disruption of Membrane by Colistin Kills Uropathogenic Escherichia coli Persisters and Enhances Killing of Other Antibiotics |
| Q58011059 | Distinct Glycan Structures of Uroplakins Ia and Ib |
| Q92538265 | Diverse Expression of Antimicrobial Activities Against Bacterial Vaginosis and Urinary Tract Infection Pathogens by Cervicovaginal Microbiota Strains of Lactobacillus gasseri and Lactobacillus crispatus |
| Q36262315 | Dual ligand/receptor interactions activate urothelial defenses against uropathogenic E. coli |
| Q34264773 | Dynamic interactions between host and pathogen during acute urinary tract infections |
| Q35134655 | Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection |
| Q64448532 | Effect of Dendrimer Generation and Aglyconic Linkers on the Binding Properties of Mannosylated Dendrimers Prepared by a Combined Convergent and Onion Peel Approach |
| Q34259004 | Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli |
| Q36150606 | Emerging drugs for bacterial urinary tract infections |
| Q35944034 | Escherichia coli uropathogenesis in vitro: invasion, cellular escape, and secondary infection analyzed in a human bladder cell infection model |
| Q34008358 | Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. |
| Q34259550 | Eukaryotic translation elongation factor 1A induces anoikis by triggering cell detachment |
| Q28238561 | Evolution of mutation rates in bacteria |
| Q64449467 | Exploring the 3D molecular architecture of Escherichia coli type 1 pili |
| Q39968965 | Extended-spectrum beta-lactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniae. |
| Q53867730 | Feline uropathogenic Escherichia coli from Great Britain and New Zealand have dissimilar virulence factor genotypes. |
| Q35131385 | Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs |
| Q34546729 | Functional urological disorders: a sensitized defence response in the bladder-gut-brain axis |
| Q34562945 | G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity. |
| Q33338212 | Gene expression profiling of inflammatory bladder disorders |
| Q46299215 | Genotypic characterization of virulence factors in Escherichia coli strains from patients with cystitis |
| Q33563129 | Genotyping of ESBL Producing Uropathogenic Escherichia coli in West of Iran |
| Q30413209 | Host response to probiotics determined by nutritional status of rotavirus-infected neonatal mice |
| Q36910650 | Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection |
| Q37033128 | Human decay-accelerating factor and CEACAM receptor-mediated internalization and intracellular lifestyle of Afa/Dr diffusely adhering Escherichia coli in epithelial cells |
| Q42919010 | Human-Restricted Bacterial Pathogens Block Shedding of Epithelial Cells by Stimulating Integrin Activation |
| Q51048257 | Hydrodynamic surface interactions enable Escherichia coli to seek efficient routes to swim upstream. |
| Q35973159 | Identification of Anti-Persister Activity against Uropathogenic Escherichia coli from a Clinical Drug Library |
| Q40276070 | Identification of a novel sequence type of Escherichia coli as the causative agent of pyelonephritis and bloodstream infection |
| Q39165446 | Immunity to uropathogens: the emerging roles of inflammasomes |
| Q36747192 | Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli. |
| Q91313698 | Improvement of Aglycone π-Stacking Yields Nanomolar to Sub-nanomolar FimH Antagonists |
| Q93000749 | Insulin receptor signaling regulates renal collecting duct and intercalated cell antibacterial defenses |
| Q33290835 | Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli |
| Q37337368 | Interleukin-8 is essential for normal urothelial cell survival |
| Q24645503 | Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex |
| Q89783450 | Intimate Attachment of Escherichia coli O157:H7 to Urinary Bladder Epithelium in the Gnotobiotic Piglet Model |
| Q26799248 | Intracellular Bacterial Communities: A Potential Etiology for Chronic Lower Urinary Tract Symptoms |
| Q37996092 | Intravital models of infection lay the foundation for tissue microbiology |
| Q37593454 | Invasion of Host Cells and Tissues by Uropathogenic Bacteria. |
| Q90265357 | Involvement of NLRP3 and NLRC4 Inflammasome in Uropathogenic E. coli Mediated Urinary Tract Infections |
| Q36911129 | LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis |
| Q36760537 | Lower Levels of Urinary Nerve Growth Factor Might Predict Recurrent Urinary Tract Infections in Women |
| Q35060254 | Macrophages rapidly transfer pathogens from lipid raft vacuoles to autophagosomes |
| Q36179492 | Major Neutrophilia Observed in Acute Phase of Human Leptospirosis Is Not Associated with Increased Expression of Granulocyte Cell Activation Markers |
| Q34820294 | Management of bacterial urinary tract infections in adult patients with diabetes mellitus |
| Q36826092 | Mast cell interleukin-10 drives localized tolerance in chronic bladder infection |
| Q27028174 | Mechanisms of pain from urinary tract infection |
| Q37123051 | Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis |
| Q39654380 | Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection |
| Q35171765 | Microbial virulence determinants and the pathogenesis of urinary tract infection |
| Q43174667 | Modulation of ureteric Ca signaling and contractility in humans and rats by uropathogenic E. coli |
| Q36845149 | Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder |
| Q38293889 | Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli |
| Q41181954 | Moraxella catarrhalis induces an immune response in the murine lung that is independent of human CEACAM5 expression and long-term smoke exposure |
| Q26863396 | NGAL-Siderocalin in kidney disease |
| Q54516605 | Neutrophil bactericidal function is defective in patients with recurrent urinary tract infections. |
| Q35098160 | New aspects of RpoE in uropathogenic Proteus mirabilis. |
| Q38186569 | New horizons: urinary incontinence in older people |
| Q58561352 | Nonantibiotic prevention and management of recurrent urinary tract infection |
| Q39072691 | Novel approaches to the treatment of bacterial biofilm infections |
| Q31085840 | O-antigen modulates infection-induced pain states |
| Q36998104 | Origins and virulence mechanisms of uropathogenic Escherichia coli |
| Q40909500 | P pilus assembly motif necessary for activation of the CpxRA pathway by PapE in Escherichia coli |
| Q34756627 | Pathogenesis of bacteriuria in women with diabetes mellitus |
| Q34297628 | Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges |
| Q33826366 | Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics |
| Q34198323 | Phylogenetic grouping and pathotypic comparison of urine and fecal Escherichia coli isolates from children with urinary tract infection. |
| Q54416579 | Plasminogen activator inhibitor-1 regulates neutrophil influx during acute pyelonephritis. |
| Q27321660 | Preferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infection |
| Q34135460 | Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. |
| Q36908434 | Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. |
| Q54605654 | Prostasin attenuates inducible nitric oxide synthase expression in lipopolysaccharide-induced urinary bladder inflammation. |
| Q61447734 | Quercetin Prevents O157:H7 Adhesion to Epithelial Cells via Suppressing Focal Adhesions |
| Q35027510 | Recent advances in the molecular basis of pathogen recognition and host responses in the urinary tract |
| Q34756585 | Recent advances into the pathogenesis of recurrent urinary tract infections: the bladder as a reservoir for uropathogenic Escherichia coli |
| Q39617000 | Reinforcement of epithelial cell adhesion to basement membrane by a bacterial pathogen as a new infectious stratagem |
| Q41909283 | Response of extraintestinal pathogenic Escherichia coli to human serum reveals a protective role for Rcs-regulated exopolysaccharide colanic acid. |
| Q30032297 | Ribonucleases 6 and 7 have antimicrobial function in the human and murine urinary tract. |
| Q35557736 | Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection |
| Q35852635 | Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage |
| Q33415985 | Roles of putative type II secretion and type IV pilus systems in the virulence of uropathogenic Escherichia coli |
| Q28589878 | SNX31: a novel sorting nexin associated with the uroplakin-degrading multivesicular bodies in terminally differentiated urothelial cells |
| Q50539828 | Secreted autotransporter toxin (Sat) triggers autophagy in epithelial cells that relies on cell detachment. |
| Q36413968 | Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection |
| Q36895740 | Sticky fibers and uropathogenesis: bacterial adhesins in the urinary tract |
| Q36902491 | Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies. |
| Q34136731 | Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections. |
| Q37074933 | TLR-mediated immune responses in the urinary tract |
| Q35944364 | TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder |
| Q36091814 | Tamm-Horsfall protein: a multilayered defence molecule against urinary tract infection |
| Q43235163 | Taurine modulates neutrophil function but potentiates uropathogenic E. coli infection in the murine bladder |
| Q28473454 | Temperature control of fimbriation circuit switch in uropathogenic Escherichia coli: quantitative analysis via automated model abstraction |
| Q49513869 | Temporal Regulation of fim Genes in Uropathogenic Escherichia coli during Infection of the Murine Urinary Tract |
| Q46817158 | The Aging Overactive Bladder: A Review of Aging-Related Changes from the Brain to the Bladder |
| Q36826891 | The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli. |
| Q92072161 | The Responses of the Ribonuclease A Superfamily to Urinary Tract Infection |
| Q42363502 | The Type VI Secretion System Plays a Role in Type 1 Fimbria Expression and Pathogenesis of an Avian Pathogenic Escherichia coli Strain |
| Q36299210 | The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections |
| Q34625661 | The epidemiology of urinary tract infection |
| Q43082857 | The genome of a blood fluke associated with human cancer |
| Q35171769 | The host response to urinary tract infection. |
| Q33256124 | The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins |
| Q37238866 | The innate immune response during urinary tract infection and pyelonephritis. |
| Q37050386 | The nature of immune responses to urinary tract infections |
| Q64449424 | The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract |
| Q34756621 | The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract |
| Q54453952 | The urokinase plasminogen activator receptor is crucially involved in host defense during acute pyelonephritis. |
| Q33471464 | Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women |
| Q34415785 | Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors |
| Q89891836 | Transurethral cystoscopy in dogs with recurrent urinary tract infections: Retrospective study (2011-2018) |
| Q35217525 | Tumor necrosis factor alpha- and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance |
| Q39922793 | Type 1 pilus-mediated bacterial invasion of bladder epithelial cells |
| Q33877935 | Ureaplasma parvum infection alters filamin A dynamics in host cells. |
| Q44258125 | Urinary tract infection in iNOS-deficient mice with focus on bacterial sensitivity to nitric oxide |
| Q54453049 | Urinary tract infection in women: new pathogenic considerations. |
| Q34222501 | Urinary tract infections in adult general practice patients. |
| Q35024973 | Urinary tract infections in women: etiology and treatment options. |
| Q27313968 | Uropathogenic E. coli Exploit CEA to Promote Colonization of the Urogenital Tract Mucosa |
| Q37371352 | Uropathogenic E. coli adhesin-induced host cell receptor conformational changes: implications in transmembrane signaling transduction |
| Q51891134 | Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells. |
| Q27312148 | Uropathogenic Escherichia coli P and Type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction |
| Q37451184 | Uropathogenic Escherichia coli Suppresses the host inflammatory response via pathogenicity island genes sisA and sisB. |
| Q34111754 | Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization |
| Q37029864 | Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway. |
| Q64123510 | Uropathogenic employs both evasion and resistance to subvert innate immune-mediated zinc toxicity for dissemination |
| Q34973621 | Uroplakins in urothelial biology, function, and disease |
| Q39097235 | Urothelial generation and regeneration in development, injury, and cancer. |
| Q34574469 | Use of Lactobacillus to prevent infection by pathogenic bacteria |
| Q33519502 | Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli |
| Q58089902 | Virulence behavior of uropathogenic Escherichia coli strains in the host model Caenorhabditis elegans |
| Q40749484 | Water consumption and urinary tract infections: an in vitro study |
| Q26767058 | Why Serological Responses during Cystitis are Limited |
| Q90292866 | yqhG Contributes to Oxidative Stress Resistance and Virulence of Uropathogenic Escherichia coli and Identification of Other Genes Altering Expression of Type 1 Fimbriae |
| Q33808284 | α-Intercalated cells defend the urinary system from bacterial infection |
Search more.